Â¥
5.54
Oct 18
New Key Statistics Module, Z-Score and F-Score
SZSE:000952 Key Ratios
Market Cap ¥ M | 1,892.72 |
Enterprise Value ¥ M | 2,586.77 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.56 |
Price/Sales | 2.85 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 690.00 |
EPS (TTM) ¥ | -0.63 |
Beneish M-Score | -2.53 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -32.60 |
y-y EBITDA Growth Rate % | -662.20 |
EV-to-EBIT | -15.77 |
EV-to-EBITDA | -15.77 |
PEG | -- |
Shares Outstanding M | 349.86 |
Net Margin (%) | -32.03 |
Operating Margin % | -20.07 |
Pre-tax Margin (%) | -32.89 |
Quick Ratio | 0.66 |
Current Ratio | 1.01 |
ROA % (ttm) | -7.09 |
ROE % (ttm) | -16.11 |
ROIC % (ttm) | -5.74 |
Dividend Yield % | -- |
Altman Z-Score | 0.84 |
SZSE:000952 Number of Guru Trades
SZSE:000952 Volume of Guru Trades
Gurus Latest Trades with SZSE:000952
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000952 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Guangji Pharmaceutical Co Ltd Insider Transactions
No Available Data